BioMarin Pharmaceutical | Créanciers Commerciaux



Trade Creditors Changement Date
Acadia Pharmaceuticals USD 16.19M 2.89M 2024-12
Agios Pharmaceuticals USD 13.73M 2.92M 2025-03
Alnylam Pharmaceuticals USD 97.4M 8.98M 2025-03
Amgen USD 2.41B 498M 2025-03
Bayer EUR 7.52B 957M 2024-12
Biogen USD 391.5M 32.7M 2025-03
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Gilead Sciences USD 833M 70M 2024-12
Incyte USD 195.54M 1.93M 2025-03
Insmed USD 77.21M 8.54M 2024-12
Ionis Pharmaceuticals USD 17.46M 25.51M 2025-03
Moderna USD 226M 179M 2025-03
Neurocrine Biosciences 110M 282.7M 2024-12
PTC Therapeutics USD 15.15M 2.12M 2025-03
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Roche Holding 4.35B 828M 2024-12
Sanofi 7.55B 118M 2024-12
Sarepta Therapeutics USD 156.1M 58.34M 2025-03
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
United Therapeutics 6M 357.9M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



BioMarin Pharmaceutical Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.